Co-Diagnostics, Inc. (CODX) Shareholders’ equity 2017–2025
Co-Diagnostics, Inc. (CODX) shareholders’ equity at each fiscal year-end, per SEC filings.
$20.6MFY2025 · since FY2017: $3.9M → $20.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $20.6M | -61.7% |
| FY2024 | $53.9M | -37.0% |
| FY2023 | $85.6M | -25.3% |
| FY2022 | $114.5M | -14.8% |
| FY2021 | $134.5M | +101.6% |
| FY2020 | $66.7M | +3739.2% |
| FY2019 | $1.7M | +264.1% |
| FY2018 | -$1.1M | -127.5% |
| FY2017 | $3.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice